Ultram and Spectazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Ultram and Spectazole together.
The phase IV clinical study analyzes what interactions people who take Ultram and Spectazole have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who take Ultram and Spectazole together, and have interactions are studied.
What is Ultram?
Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 27,263 Ultram users for its effectiveness, alternative drugs and more.
What is Spectazole?
Spectazole has active ingredients of econazole nitrate. eHealthMe is studying from 242 Spectazole users for its effectiveness, alternative drugs and more.
Number of Ultram and Spectazole reports submitted per year:
Common Ultram and Spectazole drug interactions by gender *:
female:
- Abdominal pain upper
- Calcinosis
- Hypercholesterolaemia
- Hyperlipidaemia
- Spinal disorder
- Cellulitis
- Cerebral disorder
- Cerebral ischaemia
- Cerebrovascular accident
- Dyspnoea
male:
n/a
Common Ultram and Spectazole drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Abdominal pain upper
- Calcinosis
- Hypercholesterolaemia
- Hyperlipidaemia
- Spinal disorder
- Cellulitis
- Cerebral disorder
- Cerebral ischaemia
- Cerebrovascular accident
- Dyspnoea
* Approximation only. Some reports may have incomplete information.
Do you take Ultram and Spectazole?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Ultram (27,263 reports)
- Spectazole (242 reports)
Browse all drug interactions of Ultram and Spectazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Ultram side effects:
- Pain: 2,373 reports
- Fatigue (feeling of tiredness): 2,096 reports
- Weakness: 1,701 reports
- Headache (pain in head): 1,674 reports
- Drug ineffective: 1,603 reports
- Breathing difficulty: 1,588 reports
Browse all side effects of Ultram:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Ultram interactions:
- Ultram and Aspirin: 3,040 reports
- Ultram and Neurontin: 2,885 reports
- Ultram and Prilosec: 2,369 reports
- Ultram and Lasix: 2,365 reports
- Ultram and Prednisone: 2,244 reports
- Ultram and Tylenol: 2,224 reports
- Ultram and Lyrica: 2,159 reports
- Ultram and Synthroid: 2,140 reports
- Ultram and Nexium: 2,026 reports
- Ultram and Protonix: 1,875 reports
Browse all interactions between Ultram and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride and econazole nitrate (the active ingredients of Ultram and Spectazole, respectively), and Ultram and Spectazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ultram and Spectazole.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Anxiety Aggravated and Trichotillomania - 19 seconds ago
- Androgen Deficiency and Malignant Neoplasm Progression - 20 seconds ago
- Fosamax and Bulimia - 20 seconds ago
- Milk Thistle and Urinary Incontinence - 20 seconds ago
- Carvedilol and Pulmonary Sepsis - 23 seconds ago
- Anxiety Aggravated and Skin Candida - 32 seconds ago
- Asthma and Labyrinthitis - 45 seconds ago
- Finasteride and Haemoglobin Abnormal - 47 seconds ago
- Back Pain and Ovarian Cysts - 48 seconds ago
- Restoril and Nail Abnormalities - 53 seconds ago